SCHEMBL31526577

SCHEMBL31526577

CCCC[Sn](CCCC)(CCCC)c1ncc2cc(C(C)(C)C)n(C)c2n1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.30
▸ FGFR1 P11362 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26122667 0.69 KDM4E (0.34) EGFRFGFR1
SCHEMBL26126067 0.69 MAPK14 (0.33) —
SCHEMBL26124448 0.66 ALDH1A1 (0.31) —
SCHEMBL11057987 0.63 — —
SCHEMBL20740530 0.63 CSNK1E (0.35) —
SCHEMBL29893529 0.63 KDM4E (0.33) —
SCHEMBL30048707 0.62 — —
SCHEMBL11065399 0.62 — —
SCHEMBL15331797 0.62 ADORA2A (0.30) —
SCHEMBL31526965 0.62 MAPK14 (0.40) FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076235-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-04-10 — — WO disclosed
Send feedback